Facebook Linkedin RSS Twitter Youtube
Home 2012

Hepatitis B virus

Alnylam, Arrowhead Enter Cross-Licensing Arrangement
Drug Discovery

Alnylam, Arrowhead Enter Cross-Licensing Arrangement

Late-Stage Study Results Show Dynavax’ HBV Vaccine Is Better at Protecting Diabetics than Engerix-B
Drug Discovery

Late-Stage Study Results Show Dynavax’ HBV Vaccine Is Better at Protecting Diabetics than Engerix-B

Aduro BioTech Wins $250K in SBIR Grants and Contract with UNM for Vaccine Development
Cancer

Aduro BioTech Wins $250K in SBIR Grants and Contract with UNM for Vaccine Development

Roche’s Multivirus Blood-Screening Assay Achieves CE Mark
Drug Discovery

Roche’s Multivirus Blood-Screening Assay Achieves CE Mark

Spanish Research Consortium Taps Roche Sequencing Technology for HBV and HCV Research
Infectious Diseases

Spanish Research Consortium Taps Roche Sequencing Technology for HBV and HCV Research

Abbott and Celera Sign Distribution Deal for PCR-Based KIF6 Gene Test on m2000 System
News

Abbott and Celera Sign Distribution Deal for PCR-Based KIF6 Gene Test on m2000 System

FDA Gives Abbott a Thumbs-Up for Automated HBV Monitoring Test
Bioprocessing

FDA Gives Abbott a Thumbs-Up for Automated HBV Monitoring Test

Gilead and GlaxoSmithKline Divvy Up Commercialization of Viread® for HBV in Key Asian Countries
News

Gilead and GlaxoSmithKline Divvy Up Commercialization of Viread® for HBV in Key Asian Countries

FDA Lifts Hold on Dynavax’ Phase III HBV Vaccine
Drug Discovery

FDA Lifts Hold on Dynavax’ Phase III HBV Vaccine

Merck & Co.’s Exit from Alliance Sends Dynavax Crashing
News

Merck & Co.’s Exit from Alliance Sends Dynavax Crashing

1234Page 3 of 4
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.